Journal of Medicinal Chemistry · 2006 · 17 citations · 18 references
MedicineMedicinal ChemistryPharmacologyDrug DesignMolecular PharmacologyStructure-activity RelationshipsCholinergic PharmacologyDrug-receptor InteractionsLigand BindingPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisAgonists Of Cholinergic ReceptorsCholinergic Receptor PharmacologyMuscarinic AgonistsMuscarinic Receptor PharmacologyMuscarinic Receptor SubtypesMuscarinic ReceptorsReceptorsSynthetic Analogues
As part of a continuing effort to design and synthesize highly selective muscarinic agonists for different muscarinic receptor subtypes, several tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (1) analogues were prepared and characterized. Different analogues were synthesized having hydrophilic spacers of di-, tri-, tetra-, penta(ethylene glycol) and tri(propylene glycol) separating the 1,2,5,6-tetrahydropyridine ring from the terminal heterocycle, which was either a 1,2,5-thiadiazole or 1,2,4-thiadiazole ring. Chimeric receptor and molecular modeling studies also were conducted to determine how the ligands interact with muscarinic receptors. The studies revealed that varying the distance of the terminal thiadiazole and the positioning of the methoxy group can increase binding affinity for certain muscarinic receptor subtypes (at M(2) for 13d and M(4) for 1) and enhance functional efficacy at M(4) receptors for 13e and 18b. Moreover, compound 1 exhibited antipsychotic activity as assessed by reversal of apomorphine-induced sensory motor gating deficits, suggesting potential utility in the treatment of schizophrenia.
18
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Krzysztof Palczewski, Takashi Kumasaka, Tetsuya Hori et al. · Science · 2000 · 5.6K citations
What Are the Right Targets for Psychopharmacology?
Steven E. Hyman, Wayne S. Fenton · Science · 2003 · 284 citations